Lv7
3840 积分 2022-12-19 加入
Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in Multiple Myeloma: 30 Years in the Making
22小时前
已完结
Treatment Decisions in Multiple Myeloma
1天前
已完结
Beyond maximum grade: using patient-generated data to inform tolerability of treatments for haematological malignancies
3天前
已完结
Beyond maximum grade: using patient-generated data to inform tolerability of treatments for haematological malignancies
4天前
已关闭
Beyond maximum grade: introduction to The Lancet Haematology Adverse Events Reporting Series
4天前
已关闭
Beyond maximum grade: the role of real-world digital health technologies to capture, predict, and manage treatment toxicity in haematological cancers
4天前
已关闭
Beyond maximum grade: key regulatory considerations in adverse event reporting
4天前
已关闭
Beyond maximum grade: using patient-generated data to inform tolerability of treatments for haematological malignancies
4天前
已完结
Beyond maximum grade: advancing the measurement and analysis of adverse events in malignant haematology trials in the modern era
4天前
已关闭
Beyond maximum grade: long-term toxicity and survivorship in haematological malignancies
6天前
已完结
皖公网安备34019202002308
